Well, what a way to bow out as President of the British Pharmacological Society? I think Pharmacology 2019 in Edinburgh was a spectacular success and the scientific programme was truly…
The British Pharmacological Society is delighted to announce the appointment of Rachel Lambert-Forsyth as its new Chief Executive Officer with effect from 16 March 2020.Rachel is currently Director…
The first nanobody therapy to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare life-threatening autoimmune blood-clotting disorder, has been named Drug Discovery of the…
The British Pharmacological Society and the European Laboratory Research & Innovation Group (ELRIG) UK announced today that they have formed a strategic alliance. The two-year agreement offers…
Today the Royal College of Physicians (RCP) published its case report Benefiting from the ‘research effect’, setting out how NHS trusts can better support clinicians to become research…
Morphine is sometimes prescribed in France to some opioid-dependent patients who are insufficiently relieved by or intolerant to validated substitute treatments (buprenorphine and methadone), without…
Every year, the British Pharmacological Society awards a small number of Fellowships and Honorary Fellowships. This year, 19 Fellowships and 11 Honorary Fellowships are awarded. Honorary…
Opioid drugs are widely used for pain relief, but their clinical utility is seriously limited by adverse effects, such as the risk of addiction. Opioid analgesics have been overused for many years;…
Globally, cardiovascular disease is responsible for more deaths than cancer. It is the world’s most common cause of death. Generations of researchers have put their efforts into discovering safer and…
At Pharmacology 2019, the Society will host the first in a series of annual symposia to recognise pioneers in pharmacology and drug discovery. The first recipient of this accolade will be in memory…
